http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2474424-C2
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f2ebcb543ad5bde4b5831b70926e0f68 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P5-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4196 |
filingDate | 2010-09-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2013-02-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cdb2c79e14b387ba09106b261deb60fa http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3b4dcee199666dd7d447ac3b33805c87 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c8e2d6ef34b6f27e54d132a47fbb1154 |
publicationDate | 2013-02-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | RU-2474424-C2 |
titleOfInvention | Method for correction of hyperestradiolemia and normogonadotropic hypogonadism in males |
abstract | FIELD: medicine. n SUBSTANCE: invention refers to medicine, namely andrology and may be used for correction of hyperestradiolemia and normogonadotropic hypogonadism in males. That is ensured by the aramotase blocker Letrosol in a dose individually prescribed by the blood estradiol and testosterone level. The invention provides reducing a level of estrogens ensures by blocking their synthesis from androgens, increasing a testosterone level due to blocking its aromatisation with Letrosol and stimulating by gonadotropin development. n EFFECT: as a consequence of the growing blood testosterone level and the reduced blood estradiol level ensures improved libido, normalised erection and higher sperm fertility. n 2 dwg, 2 ex |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2582273-C1 |
priorityDate | 2010-09-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 63.